“Time-to-Efficacy Outcomes by Observed Abrocitinib Dosing Patterns Among Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE REAL”. 2026. SKIN The Journal of Cutaneous Medicine 10 (3): s777. https://doi.org/10.25251/g9yw0x36.